Effect of cyclosporine on the endocrine and exocrine pancreas in kidney transplant recipients. 1988

N Yoshimura, and I Nakai, and Y Ohmori, and I Aikawa, and M Fukuda, and T Yasumura, and S Matsui, and T Hamashima, and T Oka
Department of Surgery, Kyoto Prefectural University of Medicine, Japan.

In order to assess whether cyclosporine (CsA) affects the endocrine and exocrine pancreas, 105 patient courses comprised of 87 living related donor (LRD) and 18 cadaver donor (CAD) transplants treated with cyclosporine and prednisolone (Pred) were compared with the results of historical controls of 170 LRD and 10 CAD transplants treated with azathioprine (Az) and Pred. All of the recipients were followed for over 6 months after transplantation. There were no differences in age, sex, Broca index, family history, and preoperative evaluation on diabetic dispositions between the two treatment groups. The incidence of diabetes mellitus (DM) requiring insulin therapy was higher in CsA-treated recipients (18/105, 17.1%) than in Az-treated recipients (23/180, 12.8%; P less than 0.05), although both the daily Pred and cumulative doses of methylprednisolone (MP) at the onset of DM were significantly smaller in the CsA group than in the Az group (26.1 +/- 2.2 mg v 41.4 +/- 3.4 mg, P less than 0.01 and 3,086 +/- 626 mg v 7,133 +/- 1,129 mg, P less than 0.01, respectively). Diabetic patients with CsA showed higher levels of blood glucose (401 +/- 46 mg/dL), but lower amounts of urinary glucose (40 +/- 4.3 g/d) compared with patients treated with Az (239 +/- 31 mg/dL, and 61.4 +/- 4.6 g/d, respectively, P less than 0.05). In the CsA group, the onset of DM was related to high CsA plasma trough levels (greater than 350 ng/mL) in 23% of patients. Insulin could be withdrawn within 3 months in six of eight patients who had been converted from CsA to Az.(ABSTRACT TRUNCATED AT 250 WORDS)

UI MeSH Term Description Entries
D007328 Insulin A 51-amino acid pancreatic hormone that plays a major role in the regulation of glucose metabolism, directly by suppressing endogenous glucose production (GLYCOGENOLYSIS; GLUCONEOGENESIS) and indirectly by suppressing GLUCAGON secretion and LIPOLYSIS. Native insulin is a globular protein comprised of a zinc-coordinated hexamer. Each insulin monomer containing two chains, A (21 residues) and B (30 residues), linked by two disulfide bonds. Insulin is used as a drug to control insulin-dependent diabetes mellitus (DIABETES MELLITUS, TYPE 1). Iletin,Insulin A Chain,Insulin B Chain,Insulin, Regular,Novolin,Sodium Insulin,Soluble Insulin,Chain, Insulin B,Insulin, Sodium,Insulin, Soluble,Regular Insulin
D008297 Male Males
D008775 Methylprednisolone A PREDNISOLONE derivative with similar anti-inflammatory action. 6-Methylprednisolone,Medrol,Metipred,Urbason,6 Methylprednisolone
D010195 Pancreatitis INFLAMMATION of the PANCREAS. Pancreatitis is classified as acute unless there are computed tomographic or endoscopic retrograde cholangiopancreatographic findings of CHRONIC PANCREATITIS (International Symposium on Acute Pancreatitis, Atlanta, 1992). The two most common forms of acute pancreatitis are ALCOHOLIC PANCREATITIS and gallstone pancreatitis. Acute Edematous Pancreatitis,Acute Pancreatitis,Pancreatic Parenchyma with Edema,Pancreatic Parenchymal Edema,Pancreatitis, Acute,Pancreatitis, Acute Edematous,Peripancreatic Fat Necrosis,Acute Edematous Pancreatitides,Acute Pancreatitides,Edema, Pancreatic Parenchymal,Edematous Pancreatitides, Acute,Edematous Pancreatitis, Acute,Fat Necrosis, Peripancreatic,Necrosis, Peripancreatic Fat,Pancreatic Parenchymal Edemas,Pancreatitides, Acute,Pancreatitides, Acute Edematous,Parenchymal Edema, Pancreatic,Peripancreatic Fat Necroses
D011183 Postoperative Complications Pathologic processes that affect patients after a surgical procedure. They may or may not be related to the disease for which the surgery was done, and they may or may not be direct results of the surgery. Complication, Postoperative,Complications, Postoperative,Postoperative Complication
D001786 Blood Glucose Glucose in blood. Blood Sugar,Glucose, Blood,Sugar, Blood
D003524 Cyclosporins A group of closely related cyclic undecapeptides from the fungi Trichoderma polysporum and Cylindocarpon lucidum. They have some antineoplastic and antifungal action and significant immunosuppressive effects. Cyclosporins have been proposed as adjuvants in tissue and organ transplantation to suppress graft rejection. Cyclosporines
D003920 Diabetes Mellitus A heterogeneous group of disorders characterized by HYPERGLYCEMIA and GLUCOSE INTOLERANCE.
D004359 Drug Therapy, Combination Therapy with two or more separate preparations given for a combined effect. Combination Chemotherapy,Polychemotherapy,Chemotherapy, Combination,Combination Drug Therapy,Drug Polytherapy,Therapy, Combination Drug,Chemotherapies, Combination,Combination Chemotherapies,Combination Drug Therapies,Drug Polytherapies,Drug Therapies, Combination,Polychemotherapies,Polytherapies, Drug,Polytherapy, Drug,Therapies, Combination Drug
D005260 Female Females

Related Publications

N Yoshimura, and I Nakai, and Y Ohmori, and I Aikawa, and M Fukuda, and T Yasumura, and S Matsui, and T Hamashima, and T Oka
June 1998, Transplantation proceedings,
N Yoshimura, and I Nakai, and Y Ohmori, and I Aikawa, and M Fukuda, and T Yasumura, and S Matsui, and T Hamashima, and T Oka
April 1988, Transplantation proceedings,
N Yoshimura, and I Nakai, and Y Ohmori, and I Aikawa, and M Fukuda, and T Yasumura, and S Matsui, and T Hamashima, and T Oka
April 1996, Transplantation proceedings,
N Yoshimura, and I Nakai, and Y Ohmori, and I Aikawa, and M Fukuda, and T Yasumura, and S Matsui, and T Hamashima, and T Oka
November 2005, Journal of the American Academy of Dermatology,
N Yoshimura, and I Nakai, and Y Ohmori, and I Aikawa, and M Fukuda, and T Yasumura, and S Matsui, and T Hamashima, and T Oka
January 1997, Transplantation proceedings,
N Yoshimura, and I Nakai, and Y Ohmori, and I Aikawa, and M Fukuda, and T Yasumura, and S Matsui, and T Hamashima, and T Oka
November 1992, Transplantation,
N Yoshimura, and I Nakai, and Y Ohmori, and I Aikawa, and M Fukuda, and T Yasumura, and S Matsui, and T Hamashima, and T Oka
October 1991, Scandinavian journal of gastroenterology,
N Yoshimura, and I Nakai, and Y Ohmori, and I Aikawa, and M Fukuda, and T Yasumura, and S Matsui, and T Hamashima, and T Oka
September 1977, Nihon Shokakibyo Gakkai zasshi = The Japanese journal of gastro-enterology,
N Yoshimura, and I Nakai, and Y Ohmori, and I Aikawa, and M Fukuda, and T Yasumura, and S Matsui, and T Hamashima, and T Oka
April 1988, Transplantation,
N Yoshimura, and I Nakai, and Y Ohmori, and I Aikawa, and M Fukuda, and T Yasumura, and S Matsui, and T Hamashima, and T Oka
November 1999, Transplantation,
Copied contents to your clipboard!